The development of early ascites is associated with shorter overall survival in patients with hepatocellular carcinoma treated with drug-eluting embolic chemoembolization
A single-centre cohort study was performed to identify the independent factors associated with the overall survival (OS) of hepatocellular carcinoma (HCC) patients treated with transarterial chemoembolization ...
Source: BMC Gastroenterology - Category: Gastroenterology Authors: Mar ía Pipa-Muñiz, Susana Sanmartino, Alicia Mesa, Carmen Álvarez-Navascués, Maria-Luisa González-Diéguez, Valle Cadahía, José-Eduardo Rodríguez, Florentino Vega, Manuel Rodríguez, Serafin-Marcos Costilla-García and María Varela Tags: Research article Source Type: research
More News: Cancer & Oncology | Carcinoma | Gastroenterology | Hepatocellular Carcinoma | Liver Cancer | Study